Adage Capital Partners
SWTX

Adage Capital Partners’s SpringWorks Therapeutics SWTX Stock Holding History

Adage Capital Partners’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-150,000
Closed -$4.28M – 1039
2022
Q3 		$4.28M Sell
150,000
-425,000
-74% -$12.2M 0.01% 801
2022
Q2 		$14.2M Sell
575,000
-1,300,666
-69% -$47.6M 0.03% 573
2022
Q1 		$106M Buy
1,875,666
+1,299,214
+225% +$74.3M 0.2% 108
2021
Q4 		$35.7M Sell
576,452
-189,466
-25% -$12.5M 0.06% 311
2021
Q3 		$48.6M Buy
765,918
+202,450
+36% +$15.6M 0.1% 217
2021
Q2 		$46.4M Sell
563,468
-4,467
-0.8% -$339K 0.09% 224
2021
Q1 		$41.8M Buy
567,935
+273,935
+93% +$21.5M 0.09% 245
2020
Q4 		$21.3M Buy
+294,000
New +$18.9M 0.05% 404

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return